Society for Endocrinology - a world-leading authority on hormones

Clinical practice

Society position statements

Responses to important advances or changes in treatments, or topical issues in the field of endocrinology.

 

April 2019

 

Shape of Training: Endocrinology & Diabetes Specialty Training

 

Both the Association of British Clinical Diabetologists & Society for Endocrinology recommend that Endocrinology & Diabetes specialty training must include a minimum of two years (or equivalent) of protected specialty time, with no IM commitment during this time.

October 2018

 

Obesity should be recognised as a disease

 

The Society endorses this position statement on the recognition of obesity as a disease.

November 2014 (under review)

 

Use of animals in medical research

 

The Society's position on the use of animals in medical research (original March 2010, reviewed April 2012, November 2014).

October 2012 (updated 2018)

 

Hypogonadism
Society for Endocrinology position statement on hypogonadism and ageing

 

A patient factsheet to accompany this position statement can be found on the Society’s public-facing website You & Your Hormones.

February 2019 

 

Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia

 

A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology.

October 2011  (under review)

 

Specialist Endocrinology Services
Society for Endocrinology’s information on specialist endocrinology services

 

This document explains how the wide range of endocrine conditions are best diagnosed and managed by teams of doctors working in a variety of different clinical settings.

September 2011 (updated 2017)

 

Synacthen
Use of synthetic ACTH (Synacthen) in patients with a history of asthma

 

This statement advises on the use of Synacthen in patients with a history of asthma.

September 2015
(under review)

 

Management of primary hypothyroidism.

 

The Society endorses this position statement, written by the British Thyroid Association Executive Committee in 2015, for the management of primary hypothyroidism.

July 2011 (updated 2018)

 

Inhaled Steroids
Endocrine effects of inhaled steroids in respiratory disease

 

This position statement highlights the suppressive effects of inhaled corticosteroids on the endogenous hypothalamo-pituitary-adrenal axis.

October 2010 (updated 2017)

 

Phaeochromocytoma and paraganglioma
Perioperative Preparation of Patients with Phaeochromocytoma /Paraganglioma (PPGL)

 

This statement outlines key points in the perioperative management of patients with PPGL.